Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002424242 | SCV002730388 | uncertain significance | Hereditary cancer-predisposing syndrome | 2022-10-30 | criteria provided, single submitter | clinical testing | The p.L701I variant (also known as c.2101T>A), located in coding exon 14 of the BRIP1 gene, results from a T to A substitution at nucleotide position 2101. The leucine at codon 701 is replaced by isoleucine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |